Evidence-based practice

Author(s):  
Blánaid Daly ◽  
Paul Batchelor ◽  
Elizabeth Treasure ◽  
Richard Watt

In the last 40 years, the needs of and demands for health care both in the UK and worldwide have increased dramatically. These increases are related to the population ageing, the development of new technologies and knowledge, rising patient expectations, and associated increases in professional expectations about the possibilities and potential of health care (Muir Gray 1997 ). In this period, the key policy concerns of the international health care community have been about containing costs and enabling equitable access to high quality health care, while also ensuring greater accountability, patient satisfaction, and improved public health (Lohr et al. 1998). Health care resources are finite and must be shared equitably on the basis of need, capacity to benefit, and effectiveness. The use of high quality research evidence and guidelines to inform individual patient care and population health care have become central to this process. In the mid-1970s, various writers began to question the effectiveness of medicine and the increasingly wider influence exerted by the medical profession on society. For example, McKeown (1976) mapped mortality rates for the main killer airborne diseases (tuberculosis, whooping cough, scarlet fever, diptheria, and smallpox) against contemporary advances in medicine from the mid-19th century to the early 1970s. He found that the declines in the incidence and prevalence of communicable diseases had occurred before their microbial cause had been identified and before an effective clinical intervention had been developed. McKeown concluded that the declines in mortality rates were not attributable to immunization and therapy and suggested the declines could more reasonably be attributed to better nutrition and improved housing conditions which had occurred over the period. Allied to McKeown’s historical analysis was the work of Archie Cochrane who evaluated contemporary clinical practice in the 1970s. In his seminal work Effectiveness and Efficiency , Cochrane (1972) showed that many medical treatments provided in the NHS were ineffective, inefficient, and founded on medical opinion rather than on a rigorous assessment of efficacy and effectiveness. Box 7.1 defines the terms efficacy, effective, and efficiency.

2009 ◽  
Vol 27 (4) ◽  
pp. 411-416 ◽  
Author(s):  
Matthew R. Cooperberg ◽  
John D. Birkmeyer ◽  
Mark S. Litwin

Author(s):  
Kenneth Prewitt

In the rapidly expanding sector of higher education worldwide, high quality research is disproportionately produced by a small number of research-intensive universities, probably no more than 400 worldwide. These universities are experiencing major changes, spurred by new technologies and data sources from those technologies, by the commercialization in the “knowledge economy” and competition from the for-profit private sector, and of course by opportunities and pressures of globalization itself. The phase we are in is further shaped by changes in how the state and the market set research priorities, partly by creating an accountability regime tied to timely and measurable contributions of products, services, and policies.Where does Africa fit in? It does not have competitive research-intensive universities. It does have high quality individual researchers. The author argues that its strength lies in robust regional research collaborations, coupled with serious engagement with stakeholder platforms including government, commerce, and NGOs.---Dans le secteur de l’enseignement supérieur mondial à l’expansion rapide, la recherche de grande qualité est produite disproportionnellement par un nombre restreint d’universités fortement axées sur la recherche, dont le nombre ne s’élève probablement pas à plus de 400 dans le monde entier. Ces universités sont en train de connaître des changements majeurs, déclenchés par les nouvelles technologies et les sources de données émanant de ces technologies, par la commer-cialisation dans l’ « économie du savoir » et la compétition provenant du secteur privé lucratif, et bien entendu, par des opportunités et des pressions créées par la mondialisation elle-même. La phase que nous traversons est, qui plus est, caractérisée par le changement de la manière dont l’état et le marché établissent les priorités de la recherche, partiellement en créant un régime où les instituions doivent rendre des comptes, un régime lié aux contributions opportunes et mesurables de produits, de services et de politiques.Dans ce contexte, où l’Afrique trouve-t-elle sa place ? Elle n’a pas d’universités compétitives axées fortement sur la recherche. Elle possède, néanmoins, des chercheurs individuels de grande qualité. L’auteur estime que sa force repose sur des partenariats de recherche régionaux solides, couplés à des engagements sérieux pris envers des parties prenantes comme le gouvernement, le milieu du commerce et les ONG.


2016 ◽  
Vol 23 (3) ◽  
pp. 627 ◽  
Author(s):  
Tom Chan ◽  
Concetta Tania Di Iorio ◽  
Simon De Lusignan ◽  
Daniel Lo Russo ◽  
Craig Kuziemsky ◽  
...  

Sharing health and social care data is essential to the delivery of high quality health care as well as disease surveillance, public health, and for conducting research. However, these societal benefits may be constrained by privacy and data protection principles. Hence, societies are striving to find a balance between the two competing public interests. Whilst the spread of IT advancements in recent decades has increased the demand for an increased privacy and data protection in many ways health is a special case.UK, are adopting guidelines, codes of conduct and regulatory instruments aimed to implement privacy principles into practical settings and enhance public trust. Accordingly, in 2015, the UK National Data Guardian (NDG) requested to conduct a further review of data protection, referred to as Caldicott 3.  The scope of this review is to strengthen data security standards and confidentiality. It also proposes a consent system based on an “opt-out” model rather than on “opt-in.Across Europe as well as internationally the privacy-health data sharing balance is not fixed.  In Europe enactment of the new EU Data Protection Regulation in 2016 constitute a major breakthrough, which is likely to have a profound effect on European countries and beyond.  In Australia and across North America different ways are being sought to balance out these twin requirements of a modern society - to preserve privacy alongside affording high quality health care for an ageing population.  Whilst in the UK privacy legal framework remains complex and fragmented into different layers of legislation, which may negatively impact on both the rights to privacy and health the UK is at the forefront in the uptake of international and EU privacy and data protection principles. And, if the privacy regime were reorganised in a more comprehensive manner, it could be used as a sound implementation model for other countries.


Sign in / Sign up

Export Citation Format

Share Document